About ES-AIPI

Evidence Summit (ES) on Reducing Maternal and Neonatal Mortality in Indonesia aims to support the Indonesian government as well as education and health care stakeholders to improve maternal and neonatal health in Indonesia. The program is a follow-up to a joint study conducted by Indonesian Academy of Sciences (AIPI) and US National Academy of Sciences (NAS) in 2013, which discovered that for decades, Indonesia lacks valid data and information about maternal and neonatal mortality. Evidence gathering and systematic review activities is exercised by AIPI from June 2016 to December 2017 with the support from the United States Agency for International Development (USAID).

ES will produce online Bibliography of Evidence that is available for public and recommendations from each topic area to be discussed with various stakeholders at the national consultative forum. ES results are expected to support the formulation of evidence-based health policy reform to address maternal and neonatal mortality in Indonesia.

What are the challenges faced in overcoming maternal and neonatal mortality issues? 

  • Difficulty to access results of unpublished research and good practice in maternal and neonatal health.
  • The lack of integrated information center on maternal and neonatal mortality (including information on causes, intervention efforts, problem-solving methods).
  • The lack of valid data and information as a reference to develop well-targeted and effective policy.
  • The lack of collaboration among academics, researchers, practitioners, and other stakeholders to explore the main cause of maternal and neonatal mortality, as well as formulating policies.

What we do?

  • Gathering all scientific evidence relevant to maternal and neonatal mortality determinants, approaches to life-saving interventions, and related research.
  • Managing, summarizing, and synthesizing evidence to provide a clear view of the priority measures that need to be carried out.
  • Building consensus among stakeholders to establish and interpret valid scientific evidence, as well as prioritize action plans in addressing maternal and neonatal mortality problems.

How to contribute?

  • Participating in Call for Evidence by submitting good practices and research results that have gone through a peer review process.
  • Participating in activities organized by ES team, such as Pre-Summit (March 2017) and Summit (October 2017).

Work process

  • Data collection through Call for Evidence and systematic review of articles and research related to maternal and child health in Indonesia was executed during Evidence Summit Phase I, from June 2016 to March 2017.
  • Field studies with group discussion methods and interviews to verify and confirm findings from systematic reviews as well as the extraction of good practices in various regions were conducted during Evidence Summit Phase II (April – December 2017).
  • The main event of Evidence Summit will be held on October 2017 and produce two key products, an online Bibliography of Evidence and recommendations from each topic area to be discussed with various stakeholders at the national consultative forum.